Lympho Bob

While I've been looking at stuff from the ASH conference earlier this month, there's been even more research on Follicular Lymphoma ...

Over the last couple of days, I was thinking about what I wanted to write today. And as I planned it out in my head, I noticed that it sound...

I plan to write about a few more interesting sessions from ASH that dealt with Follicular Lymphoma, but today I thought I'd let some exp...

OK, back to ASH abstracts. There is a lot of great stuff from ASH this year. I think I've covered the ones that have made big news, bu...

We're taking a short break from ASH proposals today. I saw this blog post (" Can I Please be Allowed to Have Bad Days After Cance...

The ASH Conference is now actually over (it ended Monday), but I still have lots of Follicular Lymphoma news to go through. We're starti...

In the U.S., we're dealing with a sad decline in the use of RadioImmunoTherapy (RIT). Bexxar is no longer available to patients, and Zev...